首页> 美国卫生研究院文献>Biomolecules >COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region Central Italy August–October 2020
【2h】

COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region Central Italy August–October 2020

机译:Covid-19快速抗原测试作为入境点的筛选策略:在意大利中部的拉齐奥地区经验2020年10月

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

COVID-19 pandemic is a dramatic health, social and economic global challenge. There is urgent need to maximize testing capacity. Rapid Antigen Tests (RAT) represent good candidates for point-of-care and mass surveillance testing to rapidly identify SARS-CoV-2-infected people, counterbalancing lower sensitivity vs. gold standard molecular tests with fast results and possible recurrent testing. We describe the results obtained with the testing algorithm implemented at points of entry (airports and ports) in the Lazio Region (Italy), using the STANDARD F COVID-19 Antigen Fluorescence ImmunoAssay (FIA), followed by molecular confirmation of FIA-positive samples. From mid-August to mid-October 2020, 73,643 RAT were reported to the Regional Surveillance Information System for travelers at points of entry in Lazio Region. Of these, 1176 (1.6%) were FIA-positive, and the proportion of RT-PCR-confirmed samples was 40.5%. Our data show that the probability of confirmation was directly dependent from the semi-quantitative FIA results. In addition, the molecularly confirmed samples were those with high levels of virus and that were actually harboring infectious virus. These results support public health strategies based on early mass screening campaigns by RAT in settings where molecular testing is not feasible or easily accessible, such as points of entry. This approach would contribute to promptly controlling viral spread through travel, which is now of particular concern due to the spread of SARS-CoV-2 variants.
机译:Covid-19大流行是一种戏剧性的健康,社会和经济的全球挑战。迫切需要最大化测试能力。快速抗原试验(大鼠)代表良好的候选人,用于快速鉴定SARS-COV-2感染的人的护理点和大规模监测试验,抵消较低的敏感性与黄金标准分子试验,并具有快速效果和可能的复发测试。我们使用标准F Covid-19抗原荧光免疫测定(FIA)在Lazio Region(意大利)中的进入(机场和港口)中实施的测试算法获得了所获得的结果,其次是分子阳性样品的分子确认。从8月中旬到2020年10月20日,73,643只RAT向拉齐奥地区入境点的旅行者区域监督信息系统报告。其中,1176(1.6%)为FIA阳性,RT-PCR证实样品的比例为40.5%。我们的数据表明,确认的概率直接从半定量的FIA结果中取决于。此外,分子确认的样品是具有高水平病毒的样品,其实际上是患有传染性病毒的病毒。这些结果支持基于早期群众筛选活动的公共卫生策略,大鼠在分子测试不可行或容易获得的环境中,如进入点。这种方法会有助于及时控制通过旅行的病毒传播,这是由于SARS-COV-2变体的传播,这是特别关注的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号